Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US Senator Bernie Sanders grills CEO of Novo Nordisk
Sen. Bernie Sanders grills maker of Ozempic
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
Bernie Sanders demands Ozempic producer to ‘stop ripping us off’ in Senate hearing
Senators grilled Novo Nordisk CEO Lars Jorgensen at a hearing on Tuesday about the cost of diabetes drug Ozempic and weight loss medication Wegovy, both of which are often prohibitively expensive in the United States despite their life-saving potential.
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
verywellhealth
9h
Why Is Ozempic So Expensive? Novo Nordisk Blames Prescription Drug Middlemen
"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...
2d
Nvidia's buyers, Boeing's strike, Elon Musk and Bernie Sanders on Ozempic: Business news roundup
When Nvidia (NVDA) reported $30 billion in revenue in its second-quarter earnings results, the AI chipmaker disclosed that ...
8d
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence ...
5d
on MSN
Elon Musk and Bernie Sanders agree on one thing: Ozempic
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Novo Nordisk
United States
Feedback